Treasure Island (603567.SH) subsidiary obtained moxifloxacin hydrochloride tablet drug registration certificate

Zhitongcaijing · 4d ago

Zhitong Financial App News, Zhenbao Island (603567.SH) issued an announcement. Recently, Harbin Zhenbao Pharmaceutical Co., Ltd., a wholly-owned subsidiary of the company, received the “Drug Registration Certificate” for moxifloxacin hydrochloride tablets approved and issued by the State Drug Administration. The drug is used to treat acute bacterial sinusitis, acute attacks of chronic bronchitis, community-acquired pneumonia, uncomplicated skin and skin tissue infections, complex skin and skin tissue infections, complicated intra-abdominal infections, plague, and mild abscesses without tubo-ovary or pelvic abscesses Moderate pelvic inflammatory disease.